TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.

Elisa Nemes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.